rxstat › Shortages › Alglucosidase Alfa

Alglucosidase Alfa (Myozyme) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Sep 17, 2026

Alglucosidase Alfa has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 1
Reports on file
3

Reports by product

The DIN is printed on your prescription label.

Resolved
MYOZYME
50MG · POWDER FOR SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02284863 · ended Sep 14, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
MYOZYME
50MG · POWDER FOR SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02284863 · ended Aug 17, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
MYOZYME
50MG · POWDER FOR SOLUTION · SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN 02284863 · ended Dec 6, 2022 · Demand increase for the drug.

What's happening

There are no active shortage reports for Alglucosidase Alfa. Health Canada has 3 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Alglucosidase Alfa is classified under “OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS” (ATC A16AB).

Recent changes

Common questions

When will Alglucosidase Alfa be back in stock in Canada?

Alglucosidase Alfa has no active shortage; supply is normal per Health Canada reports.

Why is Alglucosidase Alfa in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (other alimentary tract and metabolism products)

Avalglucosidase Alfa (Nexviazyme) Partial shortage 1 of 1 reported products affected · est. return Oct 5, 2026 Betaine (Cystadane) No current shortage Glycerol Phenylbutyrate (Ravicti) Discontinued 0 of 1 reported products affected Miglustat (Zavesca) No current shortage Nitisinone No current shortage Sapropterin Dihydrochloride (Kuvan) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.